Erik Roberson

Has grant

University of Alabama, Tuscaloosa

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Development of Inhibitors of the Tau-Fyn Interaction for the Treatment of Alzheimer's Disease

Open Date: 2015-07-01

Close Date: 2018-06-30

Grant: Close

Characterizing Protective Effects of Induced Tau Reduction

Open Date: 2010-04-01

Close Date: 2013-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (5)

Lize Jiskoot

Assistant professor

Erasmus University Rotterdam

NETHERLANDS

View details

Charlene Supnet

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Juan Camilo Vargas-Gonzalez

Associated Professor

University of Toronto

CANADA

View details

Alexander Santillo

Lund University

SWEDEN

View details

Henry Paulson

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Erik Roberson

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers.

The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia

Assessing Social Dominance in Mouse Models Using the Tube Test

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders

Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia

Collaborators (5)

Lize Jiskoot

Charlene Supnet

Juan Camilo Vargas-Gonzalez

Alexander Santillo

Henry Paulson

Make your next move.